Editorial comment on: Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging.
Weckermann
Dorothea
D
Department of Urology, Klinikum Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany. dorothea.weckermann@uro.augsburg-med.de
D002277:Carcinoma / Q000175:diagnosis / Q000556:secondary* / Q000601:surgery; D003937:Diagnosis, Differential; D006801:Humans; D007267:Injections; D008197:Lymph Node Excision / Q000706:statistics & numerical data*; D008198:Lymph Nodes / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D008207:Lymphatic Metastasis; D008279:Magnetic Resonance Imaging; D008297:Male; D009367:Neoplasm Staging / Q000379:methods; D010388:Pelvis; D011300:Preoperative Care / Q000379:methods; D011467:Prostate; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000601:surgery; D015203:Reproducibility of Results; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*; D013668:Technetium Tc 99m Aggregated Albumin / Q000008:administration & dosage; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D014057:Tomography, X-Ray Computed
D013668:Technetium Tc 99m Aggregated Albumin; C083602:technetium Tc 99m nanocolloid